| Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption F Megraud, S Coenen, A Versporten, M Kist, M Lopez-Brea, AM Hirschl, ... Gut 62 (1), 34-42, 2013 | 1183 | 2013 |
| Functional Adaptation of BabA, the H. pylori ABO Blood Group Antigen Binding Adhesin M Aspholm-Hurtig, G Dailide, M Lahmann, A Kalia, D Ilver, N Roche, ... Science 305 (5683), 519-522, 2004 | 513 | 2004 |
| Differences in Genotypes of Helicobacter pylori from Different Human Populations D Kersulyte, AK Mukhopadhyay, B Velapatiño, WW Su, ZJ Pan, C Garcia, ... Journal of bacteriology 182 (11), 3210-3218, 2000 | 334 | 2000 |
| Helicobacter pylori treatment: antibiotics or probiotics K Goderska, S Agudo Pena, T Alarcon Applied microbiology and biotechnology 102, 1-7, 2018 | 290 | 2018 |
| High Prevalence of Clarithromycin-Resistant Helicobacter pylori Strains and Risk Factors Associated with Resistance in Madrid, Spain S Agudo, G Pérez-Pérez, T Alarcón, M López-Brea Journal of clinical microbiology 48 (10), 3703-3707, 2010 | 188 | 2010 |
| Antibiotic resistance in Helicobacter pylori C Alba, A Blanco, T Alarcón Current opinion in infectious diseases 30 (5), 489-497, 2017 | 183 | 2017 |
| Antibiotic resistance problems with Helicobacter pylori T Alarcón, D Domingo, M López-Brea International journal of antimicrobial agents 12 (1), 19-26, 1999 | 180 | 1999 |
| Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori JY Jeong, AK Mukhopadhyay, D Dailidiene, Y Wang, B Velapatiño, ... Journal of bacteriology 182 (18), 5082-5090, 2000 | 178 | 2000 |
| Comparison of the E Test and Agar Dilution Method for Antimicrobial Suceptibility Testing of Helicobacter pylori Y Glupczynski, N Broutet, A Cantagrel, L Andersen, T Alarcon, ... European Journal of Clinical Microbiology and Infectious Diseases 21, 549-552, 2002 | 141 | 2002 |
| Prevalence of sarcopenia in acute hip fracture patients and its influence on short‐term clinical outcome JI González‐Montalvo, T Alarcón, P Gotor, R Queipo, R Velasco, R Hoyos, ... Geriatrics & gerontology international 16 (9), 1021-1027, 2016 | 139 | 2016 |
| Characterization of the gastric microbiota in a pediatric population according to Helicobacter pylori status L Llorca, G Pérez-Pérez, P Urruzuno, MJ Martinez, T Iizumi, Z Gao, ... The Pediatric infectious disease journal 36 (2), 173-178, 2017 | 114 | 2017 |
| Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international comparison with other established registries C Ojeda-Thies, P Sáez-López, CT Currie, FJ Tarazona-Santalbina, ... Osteoporosis International 30, 1243-1254, 2019 | 109 | 2019 |
| Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain ZR Palacios-Baena, J Oteo, C Conejo, MN Larrosa, G Bou, ... Journal of Infection 72 (2), 152-160, 2016 | 105 | 2016 |
| Impact of the Microbiota and Gastric Disease Development by Helicobacter pylori T Alarcón, L Llorca, G Perez-Perez Molecular pathogenesis and signal transduction by Helicobacter pylori, 253-275, 2017 | 99 | 2017 |
| Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain. M López-Brea, D Domingo, I Sanchez, T Alarcon The Journal of antimicrobial chemotherapy 40 (2), 279-281, 1997 | 90 | 1997 |
| Clarithromycin Resistance among Helicobacter pylori Strains Isolated from Children: Prevalence and Study of Mechanism of Resistance by PCR-Restriction … T Alarcón, AE Vega, D Domingo, MJ Martínez, M López-Brea Journal of clinical Microbiology 41 (1), 486-499, 2003 | 89 | 2003 |
| Five-Year Analysis of Antimicrobial Susceptibility of the Streptococcus milleri Group A Limia, ML Jimenez, T Alarcon, M Lopez-Brea European Journal of Clinical Microbiology and Infectious Diseases 18, 440-444, 1999 | 82 | 1999 |
| High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinicals isolates obtained from Spanish children S Agudo, T Alarcón, ML Brea, L Cibrelus, PU Tellería, MJ Martínez Revista Española de Quimioterapia 22 (2), 88-92, 2009 | 80 | 2009 |
| Baseline and pre-operative 1-year mortality risk factors in a cohort of 509 hip fracture patients consecutively admitted to a co-managed orthogeriatric unit (FONDA Cohort) R Menéndez-Colino, T Alarcon, P Gotor, R Queipo, R Ramírez-Martín, ... Injury 49 (3), 656-661, 2018 | 73 | 2018 |
| Activities of Polymyxin B and Cecropin A-Melittin Peptide CA(1-8)M(1-18) against a Multiresistant Strain of Acinetobacter baumannii JM Saugar, T Alarcón, S López-Hernández, M López-Brea, D Andreu, ... Antimicrobial agents and chemotherapy 46 (3), 875-878, 2002 | 70 | 2002 |
Claudio AlbaPersonal investigador, Universidad Complutense de Madriducm.es üzerinde doğrulanmış e-posta adresine sahip
